191 related articles for article (PubMed ID: 23251433)
1. The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival.
Millrud CR; Månsson Kvarnhammar A; Uddman R; Björnsson S; Riesbeck K; Cardell LO
PLoS One; 2012; 7(12):e51120. PubMed ID: 23251433
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
3. NET-producing CD16
Millrud CR; Kågedal Å; Kumlien Georén S; Winqvist O; Uddman R; Razavi R; Munck-Wikland E; Cardell LO
Int J Cancer; 2017 Jun; 140(11):2557-2567. PubMed ID: 28247912
[TBL] [Abstract][Full Text] [Related]
4. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
5. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.
Boucek J; Mrkvan T; Chovanec M; Kuchar M; Betka J; Boucek V; Hladikova M; Betka J; Eckschlager T; Rihova B
J Cell Mol Med; 2010 Jan; 14(1-2):426-33. PubMed ID: 19183242
[TBL] [Abstract][Full Text] [Related]
10. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
11. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
[TBL] [Abstract][Full Text] [Related]
12. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
[TBL] [Abstract][Full Text] [Related]
14. The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.
Czystowska M; Gooding W; Szczepanski MJ; Lopez-Abaitero A; Ferris RL; Johnson JT; Whiteside TL
Clin Cancer Res; 2013 Feb; 19(4):889-99. PubMed ID: 23363813
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Olofsson J
Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
[TBL] [Abstract][Full Text] [Related]
17. Inverse immunological responses induced by allergic rhinitis and head and neck squamous cell carcinoma.
Millrud CR; Hylander T; Kumlien Georen S; Kågedal Å; Winqvist O; Cardell LO
PLoS One; 2014; 9(1):e86796. PubMed ID: 24466243
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.
Schuler PJ; Börger V; Bölke E; Habermehl D; Matuschek C; Wild CA; Greve J; Bas M; Schilling B; Bergmann C; Trellakis S; Budach W; Gauler T; Brandau S; Lang S; Whiteside TL; Sorg RV; Hoffmann TK
Eur J Med Res; 2011 Feb; 16(2):57-62. PubMed ID: 21463982
[TBL] [Abstract][Full Text] [Related]
19. Circulating Leukocyte Alterations and the Development/Progression of Diabetic Retinopathy in Type 1 Diabetic Patients - A Pilot Study.
Obasanmi G; Lois N; Armstrong D; Lavery NJ; Hombrebueno JR; Lynch A; Wright DM; Chen M; Xu H
Curr Eye Res; 2020 Sep; 45(9):1144-1154. PubMed ID: 31997663
[TBL] [Abstract][Full Text] [Related]
20. The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
Ohashi T; Terasawa K; Aoki M; Akazawa T; Shibata H; Kuze B; Asano T; Kato H; Miyazaki T; Matsuo M; Inoue N; Ito Y
Auris Nasus Larynx; 2020 Aug; 47(4):658-667. PubMed ID: 32089351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]